APOE and Alzheimer disease: Rather, our results suggest that the effect of endogenous estrogens on brain structure may depend on AD biomarker level and APOE4 carrier status, with higher endogenous estrogen levels being most advantageous for non-APOE4 carriers with lower levels of AD biomarkers.